ClinVar Miner

Submissions for variant NM_000090.4(COL3A1):c.2805T>C (p.Pro935=)

gnomAD frequency: 0.00018  dbSNP: rs111567071
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 12
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000124412 SCV000167845 benign not specified 2014-06-09 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Illumina Laboratory Services, Illumina RCV000313108 SCV000425534 benign Ehlers-Danlos syndrome, type 4 2018-01-12 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
Labcorp Genetics (formerly Invitae), Labcorp RCV000313108 SCV000631652 likely benign Ehlers-Danlos syndrome, type 4 2024-01-11 criteria provided, single submitter clinical testing
Ambry Genetics RCV000777801 SCV000738543 likely benign Familial thoracic aortic aneurysm and aortic dissection 2017-03-13 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Center for Human Genetics, Inc, Center for Human Genetics, Inc RCV000659423 SCV000781237 likely benign Connective tissue disorder 2016-11-01 criteria provided, single submitter clinical testing
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV000755958 SCV000883643 likely benign not provided 2017-07-30 criteria provided, single submitter clinical testing
Color Diagnostics, LLC DBA Color Health RCV000777801 SCV000913793 benign Familial thoracic aortic aneurysm and aortic dissection 2018-10-15 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000124412 SCV001372394 benign not specified 2020-06-29 criteria provided, single submitter clinical testing Variant summary: COL3A1 c.2805T>C alters a non-conserved nucleotide resulting in a synonymous change. 4/4 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.00012 in 250242 control chromosomes (gnomAD). The observed variant frequency is approximately 93 fold of the estimated maximal expected allele frequency for a pathogenic variant in COL3A1 causing Aortopathy phenotype (1.3e-06), strongly suggesting that the variant is benign. To our knowledge, no occurrence of c.2805T>C in individuals affected with Aortopathy and no experimental evidence demonstrating its impact on protein function have been reported. Six ClinVar submitters (evaluation after 2014) cite the variant as benign (2x) and likely benign (4x). Based on the evidence outlined above, the variant was classified as benign.
CeGaT Center for Human Genetics Tuebingen RCV000755958 SCV001501791 likely benign not provided 2023-12-01 criteria provided, single submitter clinical testing COL3A1: BP4, BP7
Genome Diagnostics Laboratory, The Hospital for Sick Children RCV002277193 SCV002565628 uncertain significance Ehlers-Danlos syndrome 2020-03-01 criteria provided, single submitter clinical testing
All of Us Research Program, National Institutes of Health RCV000313108 SCV004826028 benign Ehlers-Danlos syndrome, type 4 2024-02-05 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV004530078 SCV004714826 likely benign COL3A1-related disorder 2022-08-11 no assertion criteria provided clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.